IMMUNE-RELATED ADVERSE EVENTS
Clinical trials for IMMUNE-RELATED ADVERSE EVENTS explained in plain language.
Never miss a new study
Get alerted when new IMMUNE-RELATED ADVERSE EVENTS trials appear
Sign up with your email to follow new studies for IMMUNE-RELATED ADVERSE EVENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in shrinking esophageal tumors before surgery
Disease control Recruiting nowThis study is testing whether adding the drug adebrelimab to standard chemotherapy before surgery can help eliminate or shrink esophageal cancer more effectively. About 25 people with stage II or III esophageal squamous cell carcinoma will receive the combination, then have surge…
Matched conditions: IMMUNE-RELATED ADVERSE EVENTS
Phase: NA • Sponsor: The Second Hospital of Shandong University • Aim: Disease control
Last updated May 26, 2026 11:37 UTC
-
Can a Low-Dose steroid tame Immunotherapy's liver side effect?
Disease control Recruiting nowThis study looks at whether a low dose of a common steroid (prednisolone) can effectively treat liver inflammation (hepatitis) that occurs as a side effect of cancer immunotherapy. About 63 cancer patients who develop moderate to severe liver inflammation will receive the low-dos…
Matched conditions: IMMUNE-RELATED ADVERSE EVENTS
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated May 26, 2026 11:35 UTC
-
Can cancer patients safely restart immunotherapy after side effects?
Knowledge-focused Recruiting nowThis study watches 500 cancer patients who had immune-related side effects from immunotherapy drugs. Researchers collect data and samples to understand these side effects better and see if it's safe to restart the same treatment. The goal is to help doctors make safer decisions a…
Matched conditions: IMMUNE-RELATED ADVERSE EVENTS
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 11:33 UTC
-
Blood marker hunt could prevent immunotherapy harm
Knowledge-focused Recruiting nowThis study aims to find blood markers that could predict serious side effects from cancer immunotherapy. Researchers will measure interferon levels in 300 cancer patients starting immunotherapy and compare them to 40 people with autoimmune diseases like lupus. The goal is to deve…
Matched conditions: IMMUNE-RELATED ADVERSE EVENTS
Sponsor: Hospital Universitario Araba • Aim: Knowledge-focused
Last updated May 26, 2026 11:30 UTC
-
New study aims to predict dangerous side effects of cancer immunotherapy
Knowledge-focused Recruiting nowThis study follows 940 adults with solid tumors who are starting immunotherapy. Researchers collect blood and tissue samples before and during treatment to track side effects, especially those affecting the brain and nerves. The goal is to find early warning signs and better unde…
Matched conditions: IMMUNE-RELATED ADVERSE EVENTS
Sponsor: Shantou University Medical College • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC